PANVAX pandemic influenza vaccine, adjuvanted 10 ml suspension for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

panvax pandemic influenza vaccine, adjuvanted 10 ml suspension for injection vial

seqirus pty ltd - influenza virus haemagglutinin, quantity: 30 microgram - injection, suspension - excipient ingredients: aluminium; dibasic sodium phosphate; calcium chloride dihydrate; potassium chloride; thiomersal; monobasic sodium phosphate; monobasic potassium phosphate; sodium chloride - prophylaxis of influenza in an officially declared pandemic situation. pandemic influenza vaccine should be used in accordance with australian health authorities' recommendations, taking into account the recommendation of the world health organisation.

FLUVAX inactivated influenza vaccine (split virion) thiomersal free 0.5mL injection syringe with attached needle 2019 Australia - English - Department of Health (Therapeutic Goods Administration)

fluvax inactivated influenza vaccine (split virion) thiomersal free 0.5ml injection syringe with attached needle 2019

seqirus pty ltd - influenza virus haemagglutinin -

CSL Bulk Influenza Vaccine (Split virion inactivated). Australia - English - Department of Health (Therapeutic Goods Administration)

csl bulk influenza vaccine (split virion inactivated).

seqirus pty ltd - influenza virus haemagglutinin, quantity: 30 microgram/ml - injection, suspension - excipient ingredients: monobasic potassium phosphate; thiomersal; calcium chloride dihydrate; dibasic sodium phosphate; sodium chloride; potassium chloride; monobasic sodium phosphate; water for injections - indicated for the prevention of influenza caused by influenza virus, types a and b.

AFLURIA QUAD Australia - English - Department of Health (Therapeutic Goods Administration)

afluria quad

seqirus pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - injection, suspension - excipient ingredients: sodium chloride; dibasic sodium phosphate; monobasic sodium phosphate; potassium chloride; monobasic potassium phosphate; calcium chloride dihydrate; water for injections - for the prevention of influenza caused by influenza virus, types a and b contained in the vaccine. the vaccine is indicated for use only in persons aged 5 years and over. for full details regarding recommendations for influenza vaccination, please refer to the relevant national immunisation guidelines.

FLUARIX TETRA inactivated split influenza vaccine suspension for injection 0.5 mL pre-filled syringe with needle Australia - English - Department of Health (Therapeutic Goods Administration)

fluarix tetra inactivated split influenza vaccine suspension for injection 0.5 ml pre-filled syringe with needle

glaxosmithkline australia pty ltd - influenza virus haemagglutinin -

Aflunov(r) Prepandemic Influenza Vaccine, H5N1 (surface antigen, inactivated, adjuvanted) 0.5mL pre-filled syringe Australia - English - Department of Health (Therapeutic Goods Administration)

aflunov(r) prepandemic influenza vaccine, h5n1 (surface antigen, inactivated, adjuvanted) 0.5ml pre-filled syringe

seqirus pty ltd - influenza virus haemagglutinin -

OPTAFLU inactivated influenza virus vaccine (surface antigens), prepared in cell cultures injection pre-filled syringe (with nee Australia - English - Department of Health (Therapeutic Goods Administration)

optaflu inactivated influenza virus vaccine (surface antigens), prepared in cell cultures injection pre-filled syringe (with nee

seqirus pty ltd - influenza virus haemagglutinin -

OPTAFLU inactivated influenza virus vaccine (surface antigens), prepared in cell cultures injection pre-filled syringe (without Australia - English - Department of Health (Therapeutic Goods Administration)

optaflu inactivated influenza virus vaccine (surface antigens), prepared in cell cultures injection pre-filled syringe (without

seqirus pty ltd - influenza virus haemagglutinin -

FluQuadri Junior New Zealand - English - Medsafe (Medicines Safety Authority)

fluquadri junior

sanofi-aventis new zealand limited - influenza virus a/michigan/45/2015 (h1n1) pdm09 - like strain 7.5ug (a/michigan/45/2015, x-275); influenza virus a/singapore/infimh-16-0019/2016 (h3n2) - like strain 7.5ug (a/singapore/infimh-16-0019/2016, nib-104); influenza virus b/brisbane/60/2008 - like strain 7.5ug (b/brisbane/60/2008 (victoria lineage)); influenza virus b/phuket/3073/2013 - like strain 7.5ug (b/phuket/3073/2013 (yamagata lineage)) - suspension for injection - 30 mcg - active: influenza virus a/michigan/45/2015 (h1n1) pdm09 - like strain 7.5ug (a/michigan/45/2015, x-275) influenza virus a/singapore/infimh-16-0019/2016 (h3n2) - like strain 7.5ug (a/singapore/infimh-16-0019/2016, nib-104) influenza virus b/brisbane/60/2008 - like strain 7.5ug (b/brisbane/60/2008 (victoria lineage)) influenza virus b/phuket/3073/2013 - like strain 7.5ug (b/phuket/3073/2013 (yamagata lineage)) excipient: octoxinol 9 phosphate buffered saline - fluquadri junior is indicated for active immunisation of influenza disease caused by influenza a subtype viruses and type b viruses contained in the vaccine. fluquadri junior is indicated for use in children aged 6 months to 35 months inclusive.

AGRIPPAL inactivated influenza (surface antigen) vaccine injection pre-filled syringe (without needle) 2015 Australia - English - Department of Health (Therapeutic Goods Administration)

agrippal inactivated influenza (surface antigen) vaccine injection pre-filled syringe (without needle) 2015

seqirus pty ltd - influenza virus haemagglutinin -